Palvella Therapeutics Q4 EPS $(1.08) Misses $(0.91) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.91) by 18.29 percent. This is a 79.89 percent increase over losses of $(5.37) per
Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.91) by 18.29 percent. This is a 79.89 percent increase over losses of $(5.37) per share from the same period last year.